Navigation Links
Amarantus BioSciences to Present at the National Investment Banking Association's (NIBA)122nd Conference in New York City
Date:6/6/2012

ities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the possible benefits of MANF therapeutic applications and/or advantages presented by Amarantus' PhenoGuard technology, as well as statements about expectations, plans and prospects of the development of Amarantus' new product candidates. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including the risks that the anticipated benefits of the therapeutic drug candidates or discovery platforms, as well as the risks, uncertainties and assumptions relating to the development of Amarantus' new product candidates, including those identified under "Risk Factors" in Amarantus' most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q and in other filings Amarantus periodically makes with the SEC. Actual results may differ materially from those contemplated by these forward-looking statements Amarantus does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation.

MEDIA CONTACTS:
Amarantus Biosciences, Inc.
Gerald Commissiong
pr@amarantus.com 
408.737.2734 x 102
Twitter: @Amarantusbio


'/>"/>
SOURCE Amarantus BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
2. TGen Drug Development recognized for economic development of Arizona biosciences
3. BD Biosciences Introduces Chemically Defined Cell Culture Media Supplement that Increases Biopharmaceutical Protein Production
4. Stanford professor honored for contributions to computational biosciences
5. Challenges for biofuels: New life cycle assessment report from Energy Biosciences Institute
6. Avantra Biosciences teams with TGen Drug Development to assist pharma
7. Human cells can copy not only DNA, but also RNA, says team from Pitt, Helicos BioSciences
8. InQ Biosciences Introduces First Fully Integrated Cell Research System
9. Energy Biosciences Institue named "Deal of Distinction" by tech-transfer group
10. John Theurer Cancer Center presents significant blood cancer research at 2012 ASCO Annual Meeting
11. Validity CTO to Present Natural ID Solutions for Improving Mobile Risk Management and User Experience at NFC Solutions Summit 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , , , , , , ... , , , , , ... proposing that changing how medical care is delivered could help prevent multiple chronic diseases and extend healthy lifespan. The idea, they argue, would be to target ... , , , , ... , , , , , ...
(Date:7/23/2014)... Washington, DC -- The planet,s soil releases about 60 ... which is far more than that released by burning ... respiration. This enormous release of carbon is balanced by ... and other plant matter, as well as by the ... studies have documented that rising temperatures increase the rate ...
(Date:7/23/2014)... BioCatch, the global leader in cognitive biometric ... named in Gartner,s Market Guide for Online Fraud Detection ... Quadrant for Web Fraud Detection. In the ... to deliver passive biometric analysis and predicted, "By 2017, ... at least 30% of one-stop fraud detection solutions - ...
Breaking Biology News(10 mins):Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5Climate change and the soil 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3
... August 12, 2013 A study published in the August ... of Child and Adolescent Psychiatry demonstrates support for the ... disorder (ASD found in the newly released Diagnostic and Statistical ... sample of 237 toddlers (aged 12-30 months) diagnosed with ASD ...
... , Aug. 12, 2013 With the explosion ... mobile devices has significantly increased over recent years. As ... payment security. During a ,card not present, process, a ... code (CVC) are not enough to completely secure a ...
... mutations linked to Parkinson,s disease might play a key role ... for the development of more effective drug treatments. In ... team of researchers from UCL, the University of Cambridge and ... gene Fbxo7 cause problems with ,mitaphagy, an essential process ...
Cached Biology News:Changes to symptom structure in DSM-5 support diagnosis of toddlers with autism spectrum disorder 2Biometrics Can Revolutionise Mobile Payment Security, says Frost & Sullivan 2Biometrics Can Revolutionise Mobile Payment Security, says Frost & Sullivan 3Biometrics Can Revolutionise Mobile Payment Security, says Frost & Sullivan 4Genetic mutations linked to Parkinson's disease 2
(Date:7/23/2014)... 23, 2014  AuraSense Therapeutics, the pioneer in developing ... regulatory and immunotherapeutic agents, announced today that ... Therapeutics, executive leadership team as chief financial ... to joining AuraSense Therapeutics, Mr. Snyder was ... of Cellular Dynamics International Inc., where he ...
(Date:7/23/2014)... DENVER , July 23, 2014  Having the ... making is vital to accelerating business growth and achieving ... American Hospital Association (AHA) Leadership Summit, July 20-22, 2014, ... prestigious panel of hospital executives and healthcare experts discussing ... Joanne Carrocino , President & Chief Executive Officer ...
(Date:7/23/2014)... , July 23, 2014 ... company of Trendlines Agtech , announced it ... Israel,s leading agricultural thermoplastics applications ... Valentis,s technology combines nanocrystalline cellulose (NCC), a ... with additional nanoparticles to produce highly improved polymeric ...
(Date:7/23/2014)... BRUSSELS , July 23, 2014 regulated ... its research and development pipeline with positive topline ... brivaracetam . This study was designed to evaluate ... (100 and 200 mg/day, without titration) compared to ... patients with partial-onset seizures, not fully controlled despite ...
Breaking Biology Technology:AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer 2MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7
... in Chicago on Ontario Street with my young friend Jessica. Just ... is six months into her first full-time job and already being ... lacks is career advancement, she told me. So this headhunter sends ... about career advancement. She didnt even want me to use the ...
... Midwest biotech businesses will soon have a chance to ... Japan. , ,The Japan External Trade Organization, or JETRO, ... to Japan this September 25 through October 1. They ... with Japanese companies. , ,Governor Jim Doyle, who just ...
... API Software announced on Monday that for the ... time and attendance application in the KLAS rankings ... API received the highest possible distinction in customer satisfaction, scoring ... terms of detail and business indicators and demonstrating an overall ...
Cached Biology Technology:Don't be muzzled in your Midwest technology job search 2Don't be muzzled in your Midwest technology job search 340 Midwest biotech organizations to explore Japanese partnerships 240 Midwest biotech organizations to explore Japanese partnerships 340 Midwest biotech organizations to explore Japanese partnerships 4API Software best in health-care customer satisfaction, says KLAS report 2
Rabbit polyclonal to L Kynurenine ( Abpromise for all tested applications). Antigen: Synthetic peptide L Kynurenine conjugated to a protein carrier. Entrez Gene ID: 8942 Swiss Protein ID...
Rabbit polyclonal to P5 ( Abpromise for all tested applications). entrezGeneID: 10954 SwissProtID: Q14554...
anti-achaete...
P8B1...
Biology Products: